china pharmaceutical group
(1093:Hong Kong Stock Exchange)

Financial Statements for china pharmaceutical group (1093)

Currency in Millions of Hong Kong Dollars	As of:	Dec 31 2009 Reclassified HKD	Dec 31 2010 Restated HKD	Dec 31 2011 Restated HKD	Dec 31 2012 HKD	4 Year Trend
Revenues		7,031.6	7,774.4	2,407.4	4,146.4
TOTAL REVENUES		7,031.6	7,774.4	2,407.4	4,146.4
Cost of Goods Sold		4,764.3	5,500.8	1,370.5	2,341.1
GROSS PROFIT		2,267.3	2,273.6	1,036.9	1,805.3
Selling General & Admin Expenses, Total		1,049.4	1,147.0	591.2	992.7
Other Operating Expenses		36.1	36.7	3.2	51.5
OTHER OPERATING EXPENSES, TOTAL		1,085.5	1,183.7	594.4	1,044.1
OPERATING INCOME		1,181.8	1,089.9	442.5	761.2
Interest Expense		-69.9	-63.8	-21.7	-60.1
Other Non-Operating Expenses, Total		1.0	8.7	-2.8	-213.4
Other Non-Operating Income (Expenses)		--	--	-2.8	-209.4
Impairment of Goodwill		--	--	--	1,810.7
Gain (Loss) on Sale of Assets		12.9	-70.1	0.1	2.4
EBT, INCLUDING UNUSUAL ITEMS		1,125.8	964.8	418.1	2,300.8
Income Tax Expense		142.8	190.0	61.0	132.0
Minority Interest in Earnings		-12.3	-23.1	-1.8	-6.6
Earnings from Continuing Operations		983.0	774.8	357.2	2,168.8
NET INCOME		970.7	751.7	355.4	2,162.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		970.7	751.7	355.4	2,162.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		970.7	751.7	355.4	2,162.2

Report Data Issue

To contact CHINA PHARMACEUTICAL GROUP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.